Herbal Monograph
Moringa
Moringa oleifera Lam.
Moringaceae (Moringa family)
Nutritive tropical food-medicine with potent anti-inflammatory isothiocyanates — leaf safe, root/bark abortifacient caution
Overview
Plant Description
Fast-growing, drought-resistant deciduous tree reaching 5–12 m in height, with soft, corky, whitish-grey bark and drooping branches giving an open canopy. Leaves are tripinnate (occasionally bipinnate), 30–60 cm long, with small, oval to elliptic leaflets 1–2 cm long that are bright green above and paler beneath. Flowers are fragrant, cream to white, bisexual, borne in axillary panicles, 1–1.5 cm across, with 5 unequal petals. Fruit is a pendulous, three-sided capsule (pod) 20–45 cm long, triangular in cross-section, containing round, dark brown seeds each with three papery wings. Seeds contain 33–41% fixed oil (ben oil or moringa oil), which is remarkably stable and resistant to oxidative rancidity. The root bark has a pungent odor reminiscent of horseradish, hence the common name. All parts of the tree have been used in traditional systems, but the LEAF is the primary medicinal and nutritive part in contemporary herbalism.
Habitat
Tropical and subtropical drylands, growing readily in sandy or loamy soils in areas with full sun and good drainage. Remarkably tolerant of poor soil, drought, and mild frost once established. Thrives in annual rainfall of 250–3,000 mm and temperatures of 25–35°C. Cannot tolerate waterlogging or prolonged freezing.
Distribution
Native to the sub-Himalayan tracts of northwestern India (Rajasthan, Punjab, Uttar Pradesh) and possibly also to parts of Pakistan and Afghanistan. Now pantropical — extensively cultivated throughout sub-Saharan Africa (major food security crop), South and Southeast Asia (Philippines, Indonesia, Thailand), the Caribbean, Central America, and increasingly in subtropical regions of the Americas and Mediterranean. India is the largest producer, with significant cultivation in Niger, Senegal, Ghana, and the Philippines.
Parts Used
Leaf (dried leaf powder or fresh leaf)
Preferred: Shade-dried leaf powder (capsules or loose); fresh leaf in culinary use; infusion for gentle daily use
The primary medicinal and nutritive part in contemporary herbal practice and the most extensively researched. Moringa leaf is simultaneously a concentrated food and a phytomedicine — it blurs the boundary between nutrition and therapeutics. Leaf powder is the basis for most supplement products. Fresh leaves are consumed as a vegetable in tropical cuisines. The leaf has the most favorable safety profile of any part of the tree.
Seed and seed oil (ben oil / moringa oil)
Preferred: Cold-pressed oil for topical/cosmetic use; crushed seed for water purification; seed extract in capsules
Seeds contain 33–41% fixed oil rich in oleic acid (up to 73%), behenic acid, and tocopherols. Ben oil is remarkably stable, resists rancidity, and has been prized since antiquity as a cosmetic and perfume base. Seeds also contain flocculating proteins used for water purification — crushed seed powder clarifies turbid water by coagulating suspended particles and reducing bacterial counts by 90–99%. Medicinally, seed extracts have shown anti-inflammatory and hypoglycemic activity in preclinical studies.
Root and root bark
Preferred: NOT RECOMMENDED for internal use in contemporary practice — historical/ethnobotanical interest only
CAUTION: Root and root bark are the parts most associated with traditional abortifacient and uterotonic activity. Root bark contains the alkaloids spirochin and moringine, and the compound pterygospermin, which has antimicrobial but also cytotoxic properties. Traditional Ayurvedic use includes root bark poultice for inflammatory conditions and internal use as a rubefacient and vesicant. Due to abortifacient risk and higher toxicity profile, root/bark preparations are NOT recommended in contemporary Western herbal practice and are the basis for the Class 2a safety classification.
Key Constituents
Glucosinolates and isothiocyanates
The glucosinolate-isothiocyanate system is the most pharmacologically distinctive feature of moringa, setting it apart from other nutritive herbs. Moringin's anti-inflammatory mechanism (NF-κB inhibition) provides molecular rationale for traditional anti-inflammatory uses. Processing method significantly affects isothiocyanate yield: gentle crushing/blending maximizes myrosinase contact and moringin generation, while high-heat processing (boiling, industrial drying above 60°C) may inactivate myrosinase and reduce isothiocyanate conversion.
Flavonoids and phenolic acids
The flavonoid-rich polyphenolic profile works synergistically with the isothiocyanate system. Quercetin and kaempferol provide broad antioxidant protection and vascular support. Chlorogenic acid specifically contributes to glucose-modulating effects. This polyphenolic diversity is a key argument for using whole-leaf preparations rather than isolated constituents.
Vitamins and micronutrients (in leaf)
Moringa's micronutrient density is the foundation of its role as a food-medicine, particularly in tropical developing countries where micronutrient deficiencies (vitamin A, iron, calcium) are prevalent. In clinical herbalism, this nutritive profile positions moringa as a nutritive tonic that simultaneously delivers phytotherapeutic activity — it nourishes while it treats. The nutritive value is complementary to, not a replacement for, the pharmacological actions of the isothiocyanates and flavonoids.
Alkaloids and other nitrogen compounds (primarily in root/bark/seed)
The alkaloid and nitrogen compound profile explains the CRITICAL difference in safety between leaf and root/bark preparations. Spirochin (abortifacient) and moringinine (cardiovascular stimulant) in root/bark are the basis for the Class 2a safety classification. Leaf preparations are largely free of these compounds, supporting the considerably better safety profile of leaf compared to root/bark.
Herbal Actions
Reduces inflammation
Moringin (the isothiocyanate from glucomoringin) is a potent NF-κB inhibitor, suppressing iNOS, COX-2, and pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) in both cell culture and animal models. Quercetin and kaempferol contribute additional anti-inflammatory activity through complementary pathways. The anti-inflammatory action is well-supported by preclinical data and is consistent across multiple traditional systems.
[4, 5]Prevents or slows oxidative damage to cells
The combined polyphenolic content (quercetin, kaempferol, chlorogenic acid) plus beta-carotene and ascorbic acid (in fresh leaf) provide potent antioxidant activity across multiple mechanisms: direct radical scavenging, metal chelation, and upregulation of endogenous antioxidant enzymes (SOD, catalase, GSH-Px). Moringa leaf extracts consistently outperform many common vegetables in in vitro antioxidant assays (ORAC, DPPH, FRAP).
[4, 5]Lowers blood pressure
Leaf preparations demonstrate modest blood pressure-lowering effects in animal models and some small human studies. Proposed mechanisms include vasodilation via quercetin and isothiocyanate effects on endothelial function, and mild diuretic activity. The hypotensive effect is generally gentle and dose-dependent.
[4, 5]Kills or inhibits the growth of microorganisms
Isothiocyanates (moringin) and pterygospermin have broad-spectrum antimicrobial activity in vitro against both gram-positive (S. aureus, B. subtilis) and gram-negative (E. coli, P. aeruginosa) bacteria. Seeds show particularly strong antimicrobial and water-purification properties. The antimicrobial action is more robust for seed-derived preparations than leaf.
[5, 7]Protects the liver from damage
Leaf extracts have demonstrated hepatoprotective effects in animal models of acetaminophen-induced and CCl4-induced liver injury, reducing ALT/AST elevations and histopathological damage. Attributed to the synergistic antioxidant activity of quercetin, chlorogenic acid, and isothiocyanates protecting hepatocytes from oxidative damage.
[4]Promotes breast milk production
Moringa leaf has a traditional reputation as a galactagogue in South Asian and Filipino folk medicine. A small number of clinical studies (primarily from the Philippines) have shown modest increases in breast milk volume in lactating mothers receiving moringa leaf capsules. The mechanism is not well-characterized but may relate to the nutritive density supporting overall lactation physiology.
[4, 8]Gradually restores proper body function and increases overall health
In the Western herbal tradition, moringa leaf functions as a nutritive alterative — gradually improving metabolic function, reducing systemic inflammation, and supporting detoxification pathways through its combined nutritive, antioxidant, and anti-inflammatory activities. This positions it similarly to nettle leaf but with a stronger anti-inflammatory pharmacological profile.
[5]Therapeutic Indications
Endocrine System
Type 2 diabetes and insulin resistance (adjunctive support)
Multiple small human trials and animal studies demonstrate hypoglycemic activity of moringa leaf. Proposed mechanisms include chlorogenic acid inhibiting glucose-6-phosphate translocase (reducing intestinal glucose absorption), isothiocyanate-mediated improvement in insulin sensitivity, and quercetin-mediated protection of pancreatic beta cells from oxidative damage. A 2012 review noted that moringa leaf powder at 1.5–2 g/day reduced fasting blood glucose in several studies. However, trials are generally small (n < 50), short-duration, and conducted primarily in India and sub-Saharan Africa. Moringa should be framed as adjunctive nutritive support, not a replacement for standard diabetes management.
[4, 6]Dyslipidemia (adjunctive support)
Animal and limited human data suggest moringa leaf reduces total cholesterol, LDL, and triglycerides while modestly increasing HDL. Chlorogenic acid and the flavonoid fraction are the proposed active constituents. Most evidence comes from animal models; human studies are small and heterogeneous.
[4, 6]Digestive System
Micronutrient deficiency with poor dietary diversity
This is moringa's strongest evidence base and its most significant global health application. Moringa leaf powder supplementation (5–10 g/day added to food) has been shown to improve vitamin A status, iron parameters, and overall nutritional indices in malnourished children and pregnant women in several developing-country studies. WHO, UNICEF, and NGOs actively promote moringa cultivation for food security. The nutritive density (beta-carotene, iron, calcium, protein, B vitamins) makes it a legitimate food-medicine for populations with limited dietary diversity.
[5, 7]Functional dyspepsia with sluggish digestion
The pungent isothiocyanate fraction acts as a digestive stimulant, consistent with the Ayurvedic classification as a katu (pungent) herb. Traditionally used to kindle agni (digestive fire). The bitter taste also supports digestive secretion through bitter receptor activation.
[5]Cardiovascular System
Metabolic syndrome with oxidative stress and low-grade inflammation
Moringa leaf addresses multiple aspects of metabolic syndrome simultaneously: anti-inflammatory isothiocyanates, glucose-lowering chlorogenic acid, lipid-modulating flavonoids, and blood pressure-lowering vasodilatory effects. This multi-target approach is well-suited to the multi-faceted pathology of metabolic syndrome. Human data are promising but limited.
[4, 6]Immune System
Chronic low-grade inflammatory states
The NF-κB inhibitory activity of moringin, combined with the broad antioxidant support from the polyphenolic fraction, positions moringa as a nutritive anti-inflammatory for chronic inflammatory conditions. Best framed as a supportive food-herb rather than a stand-alone anti-inflammatory medicine. The nutritive aspect simultaneously supports immune function in nutritionally compromised individuals.
[4]Hepatobiliary System
Hepatoprotection in toxic exposures or oxidative liver stress
Leaf extracts reduce ALT/AST and histopathological liver damage in animal models of drug-induced and chemical-induced hepatotoxicity. Mechanism attributed to polyphenolic antioxidant protection of hepatocytes. Clinical application is supportive and adjunctive.
[4]Reproductive System
Insufficient lactation (galactagogue support)
Filipino clinical tradition and a small number of studies suggest moringa leaf capsules (250–350 mg, 2x/day) modestly increase breast milk volume in postpartum women. Leaf preparations — not root/bark — are the appropriate form. This use is widespread in the Philippines and parts of Southeast Asia.
[8]Skin / Integumentary
Wound healing and skin inflammation (topical)
Moringa leaf paste and moringa oil (ben oil) have been used topically for wound healing, skin infections, and inflammatory skin conditions across Ayurvedic, African, and Filipino traditions. The antimicrobial isothiocyanates and anti-inflammatory flavonoids provide pharmacological plausibility. Ben oil is also used as a cosmetic emollient with excellent stability.
[5]Energetics
Temperature
slightly warm to neutral
Moisture
slightly dry
Taste
Tissue States
damp/stagnation, heat/inflammation, atrophy/deficiency
Moringa occupies an interesting energetic niche: it is a nutritive (sweet) herb that also has significant pungent (isothiocyanate) and bitter (flavonoid) character. In Ayurvedic energetics: Rasa (taste): katu (pungent), tikta (bitter), kashaya (astringent). Virya (energy): ushna (heating). Vipaka (post-digestive effect): katu (pungent). It increases Vata and reduces Kapha, with mild Pitta-reducing effects through its bitter taste. The pungent quality from isothiocyanates gives it a 'moving' quality that clears stagnation and dampness — this is consistent with its anti-inflammatory and metabolic-clearing actions. The nutritive density (sweet aspect) simultaneously nourishes deficient tissue states. In Western energetic terms, moringa is best suited for constitutions showing both deficiency AND stagnation — it nourishes while it clears, making it especially appropriate for metabolic syndrome patterns where inflammation and nutritional inadequacy coexist.
Traditional Uses
Ayurveda and Siddha medicine
- Shigru (Sahajan) — classified as katu-tikta rasa (pungent-bitter taste), ushna virya (heating energy), used to balance Kapha and Vata doshas
- Root bark used as a rubefacient and counterirritant for articular pain (applied externally as poultice)
- Leaf juice used internally as a digestive stimulant to kindle agni (digestive fire) and reduce āma (metabolic toxins)
- Seed preparation for intestinal parasites
- Leaf for nutritive tonic support in weakness and debility (Daurbalya)
- Flower decoction as a mild diuretic and for inflammatory conditions
- Ben oil (moringa seed oil) applied topically for joint pain, headache, and skin diseases
- Root bark has traditional use as an abortifacient and emmenagogue — this is the basis for pregnancy contraindication for root/bark preparations
"Moringa appears in classical Ayurvedic texts including the Charaka Samhita and Sushruta Samhita, classified under katu varga (pungent group). The Bhavaprakasha Nighantu describes Shigru as alleviating Kapha and Vata disorders, with particular affinity for the musculoskeletal and digestive systems. All parts of the tree are described — leaf, root, bark, flower, seed, and gum — with distinct applications for each."
[5]
African traditional medicine (pan-African use)
- Widespread use across sub-Saharan Africa as a 'miracle tree' for food security and medicine
- Leaf powder mixed into porridge and weaning foods to combat childhood malnutrition and vitamin A deficiency
- Leaf poultice for headache (applied to temples) in West African traditions
- Root decoction for malaria and febrile illness in some East African traditions
- Seed powder for water purification — crushed seeds added to turbid water to flocculate suspended solids and reduce bacterial contamination; used by NGOs and communities without access to municipal water treatment
- Leaf tea for diabetes management in Nigerian and Ghanaian folk medicine
- Seeds chewed or powdered for hypertension in Senegalese tradition
"Moringa has become one of the most important multipurpose trees in sub-Saharan African traditional medicine and nutrition. Its cultivation has been actively promoted by international development organizations (WHO, UNICEF, Church World Service, Trees for Life) for food security, water purification, and primary healthcare. The tree's ability to grow in degraded, arid soils makes it invaluable in regions most affected by malnutrition."
Filipino traditional medicine (hilot and folk practice)
- Malunggay leaves are a ubiquitous food vegetable and one of the most widely consumed greens in Filipino cuisine
- Leaf decoction or capsules used postpartum as a galactagogue (to increase breast milk production) — this is the most commonly cited Filipino medicinal use and has been the subject of several Philippine clinical studies
- Leaf poultice for wound healing and infected sores
- Root bark decoction used cautiously as an abortifacient in traditional practice (explaining pregnancy safety concerns)
"Moringa (malunggay) is deeply integrated into Filipino food culture and traditional health practice. The galactagogue use is so culturally embedded that moringa leaf capsules (marketed as Natalac and similar brands) are widely available in Philippine pharmacies as a lactation supplement."
[8]
Western herbal medicine (modern adoption)
- Adopted into Western practice primarily in the 2000s–2010s through the 'superfood' movement and global health research
- Used as a nutritive tonic leaf powder for general nutritional support, particularly for vegans, vegetarians, and those with limited dietary diversity
- Included in metabolic health protocols as an adjunctive anti-inflammatory and glucose-modulating agent
- Positioned in clinical herbalism as a nutritive alterative — improving metabolic function through simultaneous nourishment and anti-inflammatory clearing
- Less emphasis on root/bark preparations in Western practice due to safety concerns
"Moringa entered Western herbal awareness primarily through international development and nutrition research, then was amplified by the superfood marketing trend. It is increasingly recognized by clinical herbalists as more than a nutritional supplement — the isothiocyanate pharmacology gives it genuine therapeutic activity beyond simple nutrient delivery."
[4]
Modern Research
Safety and efficacy review — comprehensive overview
A 2015 review in Phytotherapy Research evaluated the safety, toxicology, and clinical efficacy data for Moringa oleifera, providing the most comprehensive English-language safety assessment available.
Findings: Moringa leaf preparations appear safe at doses of up to 6 g/day in short-term studies. Acute toxicity studies in animals showed no mortality or adverse effects at leaf extract doses up to 2,000 mg/kg. No significant adverse effects were reported in human trials of leaf powder or extract at standard doses. Root and bark preparations carry higher safety concerns (abortifacient alkaloids, cardiac-stimulant effects). The review concluded that moringa leaf is 'generally safe' but called for larger, longer-duration clinical trials.
Limitations: Most safety data come from animal studies or small, short-duration human trials. Long-term safety data (> 6 months continuous use) in humans are lacking. The review noted significant variability in product quality and standardization across commercial moringa products.
[4]
Hypoglycemic and hypolipidemic effects — clinical review
A 2012 review evaluated the evidence for moringa leaf in diabetes and dyslipidemia management.
Findings: Multiple animal studies demonstrated dose-dependent blood glucose reduction (30–50% decrease in fasting glucose in diabetic animal models). Several small human studies in India showed that moringa leaf powder (1.5–8 g/day) reduced fasting blood glucose by 13–29% in type 2 diabetic patients. Lipid-lowering effects included reductions in total cholesterol (6–14%), LDL (6–15%), and triglycerides (6–16%) in animal models and small human trials. Chlorogenic acid and isothiocyanate content were identified as key active constituents.
Limitations: Human trials were small (n = 20–55), short (3–12 weeks), primarily Indian, often not placebo-controlled, and used unstandardized leaf powder. The variability in moringa product quality makes extrapolation between studies difficult.
[6]
Nutritional profile and food security applications
A foundational review cataloging moringa's nutritional composition, global applications, and evidence for addressing malnutrition.
Findings: Moringa leaf powder contains per 100 g dry weight: protein 25–30 g, beta-carotene 16–19 mg, iron 17–28 mg, calcium 1,600–2,000 mg, potassium 1,300 mg, vitamin C 17–60 mg (dried). Fresh leaf contains substantially more vitamin C (120–220 mg/100 g). The amino acid profile is complete, containing all essential amino acids. Multiple NGO and WHO-supported programs have demonstrated improved nutritional status in malnourished children when moringa leaf powder was added to traditional foods.
Limitations: Nutrient bioavailability (particularly iron and calcium) is affected by antinutritional factors (phytates, oxalates) present in the leaf. Most nutrition intervention studies were conducted in developing countries with severely malnourished populations — results may not directly translate to well-nourished Western populations.
[7]
Anti-inflammatory mechanisms — isothiocyanate pharmacology
Preclinical studies characterizing moringin's anti-inflammatory mechanisms.
Findings: Moringin (the isothiocyanate from glucomoringin hydrolysis) inhibits NF-κB activation in macrophages and dendritic cells, suppresses iNOS and COX-2 expression, reduces production of TNF-α, IL-1β, and IL-6, and inhibits NLRP3 inflammasome assembly. In animal models of acute and chronic inflammation, moringa leaf extracts reduced paw edema (carrageenan model), joint inflammation (adjuvant-induced arthritis), and colonic inflammation. The anti-inflammatory potency of moringin is comparable to sulforaphane (from broccoli) in several in vitro assays.
Limitations: Primarily in vitro and animal data. The dose required to achieve anti-inflammatory tissue concentrations of moringin in humans after oral leaf consumption is not well-established. Processing methods that destroy myrosinase may significantly reduce in vivo isothiocyanate generation.
Hepatoprotective effects — animal models
Several animal studies have evaluated moringa leaf extracts for protection against drug-induced and chemical-induced liver injury.
Findings: Moringa leaf extracts (aqueous and ethanolic) reduced ALT, AST, and ALP elevations in animal models of acetaminophen-induced and carbon tetrachloride-induced hepatotoxicity. Histopathological examination showed preserved hepatic architecture and reduced necrotic areas. The hepatoprotective effect was dose-dependent and attributed to the combined antioxidant capacity of quercetin, chlorogenic acid, and isothiocyanates reducing oxidative damage to hepatocyte membranes and mitochondria.
Limitations: All animal data. No human clinical trials for hepatoprotection. Doses used in animal studies may not be directly achievable with standard human dosing of leaf powder.
[4]
Water purification — seed protein coagulation
Studies on moringa seed powder as a natural coagulant for water purification, one of the most practically significant applications globally.
Findings: Crushed moringa seeds contain cationic proteins that act as natural coagulants, binding to suspended particulate matter and bacteria in turbid water. Treatment with moringa seed powder (50–150 mg/L of water) reduced turbidity by 90–99% and reduced bacterial counts (E. coli, fecal coliforms) by 90–99.9% within 1–2 hours. The active flocculating protein has been partially characterized and is heat-stable. This technology is deployed by WHO-supported programs in communities without access to chlorination or filtration.
Limitations: Not a complete water purification method — does not remove dissolved chemicals, viruses, or all pathogens. Best suited as a primary treatment step in resource-limited settings. Seed quality and freshness affect efficacy.
[7]
Galactagogue effect — clinical studies
Philippine clinical studies evaluated moringa leaf capsules as a galactagogue in postpartum women.
Findings: In a double-blind, placebo-controlled trial of 68 postpartum women, moringa leaf capsules (250 mg, twice daily) significantly increased breast milk volume compared to placebo by days 4–5 postpartum. The effect was most pronounced in mothers of preterm infants. A subsequent open-label study confirmed increased milk production with moringa supplementation. The mechanism is not clearly established but is hypothesized to relate to the nutritive support (iron, calcium, protein) improving overall lactation physiology.
Limitations: Small sample sizes. Primarily Philippine study populations. The 2000 study was well-designed but has not been replicated in large multicenter trials. Dose-response relationships are not well-characterized.
[8]
Phytochemistry — comprehensive review of constituents
A comprehensive phytochemical review cataloging over 200 identified compounds in various parts of Moringa oleifera.
Findings: Major identified compound classes include: glucosinolates and isothiocyanates (glucomoringin, moringin — primarily in leaf and seed), flavonoids (quercetin, kaempferol, myricetin glycosides — primarily in leaf), phenolic acids (chlorogenic acid, gallic acid, ellagic acid), alkaloids (moringine, moringinine, spirochin — primarily in root/bark), tannins, saponins, phytosterols (beta-sitosterol, stigmasterol), terpenes, and vitamins. The chemical profile differs dramatically between plant parts, explaining the different pharmacological and safety profiles of leaf vs. root/bark preparations.
Limitations: Compound identification and quantification vary significantly between studies due to different extraction methods, geographic sources, and analytical techniques. Standardization of moringa products remains a major challenge.
[5]
Preparations & Dosage
Capsule / Powder
Strength: Whole leaf powder or concentrated extract (5:1 to 10:1). Products standardized to isothiocyanate content are preferred for therapeutic use.
LEAF POWDER CAPSULES: Fill capsules with shade-dried, finely ground Moringa oleifera leaf powder from a reputable source. Ensure the powder retains dark green color (not yellow — yellowing indicates vitamin degradation from improper drying). For standardized extracts, look for products specifying isothiocyanate or total polyphenol content.
Leaf powder: 500–1000 mg per capsule, 2–6 capsules daily (1–6 g total daily powder). Concentrated extract (10:1 or similar): 250–500 mg, 1–2 capsules daily. For metabolic support (glucose/lipid modulation): 1.5–3 g leaf powder daily appears effective based on available clinical data.
1–3 times daily with meals.
May be used long-term as a nutritive supplement. For specific therapeutic goals (glucose management, lipid reduction), assess response at 8–12 weeks.
As a food supplement in children over 2 years, 0.5–2 g leaf powder daily mixed into food is used in developing-country nutrition programs. Medicinal dosing: use only under qualified practitioner supervision.
Leaf powder closest to traditional nutritive use and retains the full constituent profile. Processing temperature is critical: drying above 60°C degrades myrosinase (reducing isothiocyanate generation) and vitamins. Look for 'shade-dried' or 'low-temperature dried' specifications. Capsules offer dose precision over loose powder.
Infusion (Tea)
Strength: 2–4 g dried leaf per 200–250 mL water
LEAF TEA: Place 2–4 g of dried moringa leaf (whole or coarsely ground, NOT fine powder which passes through strainers) in a cup. Pour 200–250 mL of freshly boiled water over the leaf. Cover and steep for 5–10 minutes. Strain and drink. May be blended with mint, lemon, ginger, or other herbs for palatability. Leaf infusion has a mild, pleasant, slightly earthy-green flavor.
1 cup (2–4 g dried leaf per cup), 1–3 times daily.
1–3 times daily.
May be used as a daily nutritive tea long-term.
Half a cup, 1–2 times daily for children over 5 years as a nutritive tea.
Infusion is a gentler and more traditional preparation than concentrated extracts. Water extraction captures the hydrophilic flavonoids (quercetin glycosides, chlorogenic acid) effectively but may not fully extract the glucosinolate/isothiocyanate fraction (which benefits from tissue disruption and myrosinase activation). For maximum isothiocyanate benefit, combining tea with powdered leaf (where tissue cells are disrupted) is preferable.
[5]
Tincture
Strength: 1:5, 45–50% ethanol (dried leaf)
LEAF TINCTURE: Macerate dried moringa leaf in 45–50% ethanol at a ratio of 1:5. Steep 4–6 weeks with regular agitation. Strain and press. The tincture will be dark green.
2–5 mL, 2–3 times daily.
2–3 times daily.
8–12 weeks, then reassess.
Not the preferred preparation for children; use leaf powder or infusion instead.
Tincture is not a traditional preparation for moringa but is used in Western herbal practice for convenience and formula compatibility. Ethanol extraction captures a different constituent profile than water: better extraction of isothiocyanates and lipophilic flavonoid aglycones, but may miss some water-soluble glycosides. Moringa tincture is best used as part of formula blends rather than as a stand-alone preparation.
[4]
Fresh Juice / Expressed Juice
Strength: Fresh leaf juice
FRESH LEAF JUICE: Blend or juice fresh moringa leaves with a small amount of water. Strain if desired. Consume immediately — fresh juice oxidizes and degrades rapidly. Can be added to smoothies or mixed with fruit juice.
30–60 mL fresh juice, 1–2 times daily.
1–2 times daily.
Seasonal or as available.
15–30 mL mixed into smoothie or food.
Fresh juice provides the highest vitamin C content, active myrosinase (maximizing isothiocyanate generation from glucomoringin), and a full spectrum of water-soluble and lipid-soluble nutrients. This is closest to traditional culinary-medicinal use in tropical regions. The main limitation is availability — fresh moringa leaves are only readily available in tropical climates or from specialty suppliers.
[5]
Safety & Interactions
Class 2a
Not to be used during pregnancy (AHPA Botanical Safety Handbook)
Contraindications
Root bark contains the alkaloid spirochin, which has documented uterotonic and abortifacient activity in animal models. Root bark preparations have been used traditionally as abortifacients in Ayurvedic and Filipino folk practice. ALL root and bark preparations are absolutely contraindicated in pregnancy. The Class 2a classification is based primarily on this root/bark concern.
Moringa leaf as a FOOD (culinary quantities) is consumed by pregnant women throughout the tropics without documented adverse reproductive effects. However, concentrated leaf extracts at high medicinal doses have not been adequately studied for reproductive safety. The precautionary principle suggests using moringa leaf only in food/culinary quantities during pregnancy, not in concentrated medicinal doses (capsules, tinctures, high-dose powder).
Rare but documented. Cross-reactivity with other Moringaceae species is possible.
Drug Interactions
| Drug / Class | Severity | Mechanism |
|---|---|---|
| Insulin and sulfonylureas (glipizide, glyburide, glimepiride) (Hypoglycemic agents (direct glucose-lowering)) | moderate | Moringa leaf has demonstrated hypoglycemic activity through chlorogenic acid-mediated inhibition of intestinal glucose absorption and isothiocyanate-mediated improvement of insulin sensitivity. When combined with insulin or sulfonylureas, additive hypoglycemia can occur. |
| Metformin (Biguanide (hypoglycemic)) | minor | Additive glucose-lowering effect. Metformin reduces hepatic glucose output and improves insulin sensitivity; moringa reduces intestinal glucose absorption and may improve insulin sensitivity through overlapping mechanisms. |
| Antihypertensive medications (ACE inhibitors, ARBs, calcium channel blockers, diuretics) (Antihypertensives) | minor | Additive blood pressure-lowering effect. Moringa leaf has demonstrated mild vasodilatory and hypotensive activity in animal models and some human studies. |
| Levothyroxine (Synthroid, Levoxyl) (Thyroid hormone replacement) | minor | Some animal data suggest moringa leaf may affect thyroid hormone levels — isothiocyanates from cruciferous-type plants can potentially interfere with iodine uptake and thyroid peroxidase activity. The clinical significance for moringa specifically is not well-established, but the structural similarity of moringin to goitrogen-like isothiocyanates warrants caution. |
| Cytochrome P450 substrates (CYP3A4, CYP1A2) (CYP-metabolized drugs) | theoretical | Isothiocyanates are known inducers of Phase II detoxification enzymes and may modulate Phase I (CYP) activity. Some in vitro data suggest moringa extracts may inhibit CYP3A4 and CYP1A2 at high concentrations. |
Pregnancy & Lactation
Pregnancy
unsafe
Lactation
likely safe
PREGNANCY: Root and bark preparations are absolutely contraindicated (abortifacient alkaloid spirochin). Leaf as a FOOD in culinary quantities is consumed safely by millions of pregnant women in tropical countries without documented adverse reproductive effects. However, high-dose medicinal leaf preparations (capsules, concentrated extracts) lack adequate reproductive safety studies and should be avoided as a precaution. The Class 2a classification reflects the root/bark risk, but the precautionary principle extends to high-dose leaf. LACTATION: Moringa leaf is traditionally and currently used as a galactagogue in Southeast Asia. Small clinical studies suggest it modestly increases breast milk production. Leaf preparations in standard doses appear safe during lactation and may be beneficial. Root/bark preparations should still be avoided.
Adverse Effects
References
Monograph Sources
- [1] Gardner Z, McGuffin M (eds.). American Herbal Products Association's Botanical Safety Handbook, Second Edition. CRC Press, Boca Raton (2013)
- [2] Bone K, Mills S. Principles and Practice of Phytotherapy: Modern Herbal Medicine, Second Edition. Churchill Livingstone/Elsevier, Edinburgh (2013)
- [3] Chevallier A. Encyclopedia of Herbal Medicine, Third Edition. DK Publishing, London (2016)
Clinical Studies
- [4] Stohs SJ, Hartman MJ. Review of the Safety and Efficacy of Moringa oleifera. Phytotherapy Research (2015) ; 29 : 796-804 . DOI: 10.1002/ptr.5325
- [5] Anwar F, Latif S, Ashraf M, Gilani AH. Moringa oleifera: a food plant with multiple medicinal uses. Phytotherapy Research (2007) ; 21 : 17-25 . DOI: 10.1002/ptr.2023
- [6] Mbikay M. Therapeutic Potential of Moringa oleifera Leaves in Chronic Hyperglycemia and Dyslipidemia: A Review. Frontiers in Pharmacology (2012) ; 3 : 24 . DOI: 10.3389/fphar.2012.00024
- [7] Fahey JW. Moringa oleifera: A Review of the Medical Evidence for Its Nutritional, Therapeutic, and Prophylactic Properties. Part 1. Trees for Life Journal (2005) ; 1 : 5
- [8] Estrella MCP, Mantaring JBV, David GZ, Taup MA. A double-blind, randomized controlled trial on the use of malunggay (Moringa oleifera) for augmentation of the volume of breastmilk among non-nursing mothers of preterm infants. Philippine Journal of Pediatrics (2000) ; 49 : 3-6
Traditional Texts
- [9] Hoffmann D. Medical Herbalism: The Science and Practice of Herbal Medicine. Healing Arts Press, Rochester, VT (2003)
Last updated: 2026-03-23 | Status: published
Unlock the Full Materia Medica
This monograph is part of our complete evidence-based herbal reference. Enter your email to get free, unlimited access to all of our monographs.
No spam, ever. Unsubscribe anytime.
You're In!
You now have full access to all of our herbal monographs.